Unique ID issued by UMIN | UMIN000011198 |
---|---|
Receipt number | R000013122 |
Scientific Title | The evaluation of the efficacy and the safety of rikkunshito on anorexia in elderly dementia patients |
Date of disclosure of the study information | 2013/07/16 |
Last modified on | 2013/07/16 14:41:30 |
The evaluation of the efficacy and the safety of rikkunshito on anorexia in elderly dementia patients
The Effect of rikkunshito on anorexia in elderly dementia patients
The evaluation of the efficacy and the safety of rikkunshito on anorexia in elderly dementia patients
The Effect of rikkunshito on anorexia in elderly dementia patients
Japan |
Elderly dementia patients
Gastroenterology | Neurology | Geriatrics |
Others
NO
To evaluate efficacy and safety of rikkunshito in elderly dementia patients with anorexia
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
Change of food intake before and after treatment of rikkunshito
Evaluation of psychological symptoms(NPI-NH), appetite level(NPI-NH), cognitive function(MMSE), activities of daily living(Barthel index), body weight and nutrition(geriatric nutritional risk index)
Change of cerebral blood flow using SPECT
Safety of rikkunshito
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Oral administration of rikkunshito
(2.5g t.i.d) before meals for 8 weeks
65 | years-old | <= |
85 | years-old | >= |
Male and Female
Selection criterion at enrollment
1) Patients who were diagnosed as dementia according to DMS-IV-TR
2) Patients who were diagnosed as having anorexia according to NPI-NH and percentage of food consumed
3) hospitalized patients
4)clinical dementia rating(CDR)≤2
5) Patients for whom oral administration was possible
6)Agreement to sigh an informed consent
1) Patients with serious complications (liver, kidney, heart, blood, or metabolic disorders)
2) Patients with gastrectomy
3)Patients who need to take enteral nutrition
4) patients with a history of hypersensitivity to traditional Japanese medicine
5) Patients who received drugs prohibited for concomitant use within 2 weeks before treatment of rikkunshito
6) Patients under medical treatment of gastrointestinal disorders (peptic ulcer, gastrointestinal bleeding, mechanical ileus or gastrointestinal perforation) and cancer
7) Patients considered inappropriate by the study investigator
20
1st name | |
Middle name | |
Last name | Eizo Iseki |
Juntendo Tokyo Koto Geriatric Medical Center, Juntendo University School of Medicine
PET-CT Dementia Reseach Center
3-3-20 Shinsuna, Koto-ku, Tokyo, Japan
1st name | |
Middle name | |
Last name |
Juntendo Tokyo Koto Geriatric Medical Center, Juntendo University School of Medicine
PET-CT Dementia Reseach Center
3-3-20 Shinsuna, Koto-ku, Tokyo, Japan
Juntendo Tokyo Koto Geriatric Medical Center, Juntendo University School of Medicine
TSUMURA & CO.
Profit organization
NO
2013 | Year | 07 | Month | 16 | Day |
Unpublished
Open public recruiting
2012 | Year | 10 | Month | 31 | Day |
2013 | Year | 08 | Month | 01 | Day |
2013 | Year | 07 | Month | 16 | Day |
2013 | Year | 07 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013122